ARIA: Real-world utilization and outcomes with dacomitinib first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer among Asian patients – A multi center chart review (A7471067) First published 02/12/2021 Last updated 02/12/2021 EU PAS number:EUPAS44543 Study Ongoing